ULTA:NASDAQUlta Beauty, Inc. Analysis
Data as of 2026-03-10 - not real-time
$646.72
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Ulta Beauty continues to post solid top‑line momentum, with revenue climbing roughly 13% YoY and operating margins holding above 10%. The company’s profitability is exceptional – a 48% ROE and nearly 10% net margin – but the balance sheet shows a high debt‑to‑equity ratio near 98%, which tempers the upside. Valuation metrics sit at a PE of ~25x and a forward PE under 23x, while the price‑to‑book ratio exceeds 10x, suggesting the stock is priced for growth rather than pure value. Analyst consensus remains a Buy with median price targets around $717, and the recent endorsement from Jim Cramer adds a layer of positive sentiment.
Technically, the share trades around $647, below its 20‑day (675) and 50‑day (663) moving averages but comfortably above the 200‑day line (553), indicating a longer‑term bullish bias. Momentum indicators are mixed: the MACD is in a bearish configuration and the RSI sits near 42, hinting at modest downside risk, while support near $615 and resistance near $715 define a clear trading range. Volatility is elevated at roughly 28% 30‑day, yet beta below 1 points to lower market‑wide swings. The “Extreme Greed” sentiment on the fear‑greed index and recent price spikes to all‑time highs reinforce a short‑term rally potential, though caution is warranted given the high leverage and price proximity to short‑term averages.
Technically, the share trades around $647, below its 20‑day (675) and 50‑day (663) moving averages but comfortably above the 200‑day line (553), indicating a longer‑term bullish bias. Momentum indicators are mixed: the MACD is in a bearish configuration and the RSI sits near 42, hinting at modest downside risk, while support near $615 and resistance near $715 define a clear trading range. Volatility is elevated at roughly 28% 30‑day, yet beta below 1 points to lower market‑wide swings. The “Extreme Greed” sentiment on the fear‑greed index and recent price spikes to all‑time highs reinforce a short‑term rally potential, though caution is warranted given the high leverage and price proximity to short‑term averages.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- MACD in bearish territory suggesting limited upside
- Price near short‑term support at $615
- Elevated 30‑day volatility (~28%)
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Strong revenue growth and high ROE
- Analyst consensus buy with median target $717
- Long‑term bullish trend above the 200‑day SMA
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Durable consumer demand in the beauty segment
- Robust operating margins and cash flow generation
- Strategic brand positioning reinforced by positive media sentiment
Key Metrics & Analysis
Financial Health
Revenue Growth12.90%
Profit Margin9.93%
P/E Ratio24.8
ROE47.97%
ROA15.15%
Debt/Equity97.78
P/B Ratio10.9
Op. Cash Flow$1.4B
Free Cash Flow$975.3M
Technical Analysis
TrendBullish
RSI41.6
Support$615.00
Resistance$714.97
MA 20$675.10
MA 50$663.27
MA 200$552.94
MACDBearish
VolumeStable
Fear & Greed Index80.34
Valuation
Fair Value$464.62
Target Price$688.83
Upside/Downside6.51%
GradeFair
TypeBlend
Risk Assessment
Beta0.88
Volatility27.63%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.